Abstract
BackgroundImmune-related adverse events (irAE) are major barriers of clinical management and further development of cancer immunotherapy. In this study, we used mass cytometry to characterize the immune system before and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
